Breaking News Instant updates and real-time market news.

ABEO

Abeona Therapeutics

$10.04

-0.005 (-0.05%)

06:09
10/12/18
10/12
06:09
10/12/18
06:09

Mizuho starts Abeona Therapeutics with Buy rating, $17 price target

Mizuho analyst Difei Yang last night initiated coverage of Abeona Therapeutics with a Buy rating and $17 price target. With two indications progressing towards phase 3 pivotal trials, Abeona is well positioned to address unmet needs in two rare diseases, Yang tells investors in a research note. She believes EB-101 for the treatment of recessive dystrophic epidermolysis bullosa has shown encouraging results in Phase 1/2 trials and that ABO-102 for the treatment of Sanfilippo syndrome Type A shows promise with early positive biomarker data.

ABEO Abeona Therapeutics
$10.04

-0.005 (-0.05%)

06/27/18
06/27/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Zimmer Biomet (ZBH) initiated with an Underperform at Bernstein. 2. Abeona Therapeutics (ABEO) initiated with a Buy at B. Riley FBR. 3. Johnson & Johnson (JNJ) initiated with a Market Perform at Bernstein. 4. T-Mobile (TMUS) initiated with an Overweight at Barclays. 5. Scynexis (SCYX) initiated with a Buy at Maxim. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
07/19/18
LTCO
07/19/18
NO CHANGE
Target $38
LTCO
Buy
Krystal Biotech price target raised to $38 from $23 at Ladenburg
Ladenburg analyst Wangzhi Li raised his price target for Krystal Biotech (KRYS) to $38 from $23, while reiterating a Buy rating on the shares. The analyst notes that KB103 Phase 1 data in dystrophic epidermolysis bullosa is on track for Q4 report with first patients being dosed for over 2 months now. This indicates good safety so far for the first patients dosed, he contends. As only 3-6 patients are expected to be needed for the whole Phase 1 trial, the analyst believes Krystal Biotech could potentially initiate a pivotal study in 1H 2019. Abeona (ABEO) expects to start a pivotal trial later this year for its autologous personalized ex vivo gene therapy for DEB, which could help establish the regulatory endpoint and pathway for DEB and KB103, Li adds.
08/17/18
SBSH
08/17/18
NO CHANGE
SBSH
Buy
Start of Phase 3 trial for EB-101 an important catalyst for Abeona, says Citi
Following the premature publication of a draft protocol for Abeona Therapeutics' EB-101 trial by the company's collaborator, Citi analyst Liav Abraham said the start of this pivotal trial represents an important near-term catalyst for the stock. The analyst, who said that the Phase I/II trial for EB-101 in recessive dystrophic epidermolysis bullosa delivered "compelling data" on wound closure at 3 and 6-months, keeps a Buy rating on Abeona shares.
10/11/18
MZHO
10/11/18
INITIATION
MZHO
Buy
Abeona Therapeutics initiated with a Buy at Mizuho
Mizuho analyst Difei Yang initiated Abeona Therapeutics with a Buy and $17 price target.

TODAY'S FREE FLY STORIES

HSY

Hershey

$110.01

0.315 (0.29%)

12:09
02/20/19
02/20
12:09
02/20/19
12:09
Hot Stocks
Hershey reaffirms 2019 guidance at CAGNY Conference »

Hershey said that in a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 03

    Mar

KNX

Knight-Swift

$34.96

0.73 (2.13%)

12:05
02/20/19
02/20
12:05
02/20/19
12:05
Options
Knight Transportation call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 21

    Feb

12:05
02/20/19
02/20
12:05
02/20/19
12:05
General news
U.S. corporate bond update: the calendar remains active. »

U.S. corporate bond…

DNLI

Denali Therapeutics

$21.44

-0.16 (-0.74%)

12:03
02/20/19
02/20
12:03
02/20/19
12:03
Hot Stocks
Denali granted orphan status for mucopolysaccharidosis treatment »

The FDA granted Denali…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RDY

Dr. Reddy's

$35.97

-0.45 (-1.24%)

12:03
02/20/19
02/20
12:03
02/20/19
12:03
Hot Stocks
Dr. Reddy's announces re-launch of buprenorphine, naloxone sublingual film »

Dr. Reddy's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

HSY

Hershey

$109.86

0.165 (0.15%)

12:01
02/20/19
02/20
12:01
02/20/19
12:01
Earnings
Hershey backs FY19 adjusted EPS growth view of 5%-7%, consensus $5.64 »

Backs FY19 net sales…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 03

    Mar

QTT

Qutoutiao

$12.66

0.25 (2.01%)

12:01
02/20/19
02/20
12:01
02/20/19
12:01
Downgrade
Qutoutiao rating change  »

Qutoutiao downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Mar

BHC

Bausch Health

$23.23

-1.94 (-7.71%)

12:00
02/20/19
02/20
12:00
02/20/19
12:00
Hot Stocks
Bausch Health falls -7.7% »

Bausch Health is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 20

    Feb

  • 25

    Feb

  • 25

    Feb

  • 25

    Feb

  • 12

    Mar

  • 12

    Mar

IDT

IDT Corp

$6.48

-0.68 (-9.50%)

12:00
02/20/19
02/20
12:00
02/20/19
12:00
Hot Stocks
IDT Corp falls -9.1% »

IDT Corp is down -9.1%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OMI

Owens & Minor

$6.62

-1.32 (-16.62%)

12:00
02/20/19
02/20
12:00
02/20/19
12:00
Hot Stocks
Owens & Minor falls -16.6% »

Owens & Minor is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

I

Intelsat

$24.38

2.755 (12.74%)

12:00
02/20/19
02/20
12:00
02/20/19
12:00
Hot Stocks
Intelsat rises 12.8% »

Intelsat is up 12.8%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 25

    Feb

  • 25

    Feb

  • 25

    Feb

  • 11

    Mar

  • 11

    Mar

QUAD

Quad/Graphics

$16.58

2.04 (14.03%)

12:00
02/20/19
02/20
12:00
02/20/19
12:00
Hot Stocks
Quad/Graphics rises 14.4% »

Quad/Graphics is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

LKSD

LSC Communications

$9.47

1.18 (14.23%)

12:00
02/20/19
02/20
12:00
02/20/19
12:00
Hot Stocks
LSC Communications rises 14.6% »

LSC Communications is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLNE

Clean Energy

$2.23

0.24 (12.06%)

11:58
02/20/19
02/20
11:58
02/20/19
11:58
Hot Stocks
Clean Energy jumps 12% after seeing demand increases for RNG from refuse sector »

Clean Energy Fuels,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Mar

  • 12

    Mar

TKC

Turkcell

$6.97

0.06 (0.87%)

11:56
02/20/19
02/20
11:56
02/20/19
11:56
Hot Stocks
Breaking Hot Stocks news story on Turkcell 

Turkcell trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 14

    Mar

  • 19

    Mar

DDAIF

Daimler AG

$0.00

(0.00%)

11:48
02/20/19
02/20
11:48
02/20/19
11:48
Periodicals
German prosecutors launch new probe into Daimler, Reuters reports »

Prosecutors in Germany…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

IQ

iQIYI

$22.76

0.43 (1.93%)

11:45
02/20/19
02/20
11:45
02/20/19
11:45
Options
iQiyi call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

  • 20

    Mar

11:45
02/20/19
02/20
11:45
02/20/19
11:45
General news
Treasury's $18 B 2-year FRN reopening was a little soft »

Treasury's $18 B…

11:41
02/20/19
02/20
11:41
02/20/19
11:41
Conference/Events
UBS services analyst to hold an analyst/industry conference call »

Services Analyst Geiger,…

DVN

Devon Energy

$31.18

2.87 (10.14%)

11:41
02/20/19
02/20
11:41
02/20/19
11:41
Hot Stocks
Devon Energy sees FY19 total production 294-309 MBoe/d »

Sees FY19 oil production…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 20

    Feb

  • 27

    Feb

  • 28

    Feb

  • 22

    May

WIX

Wix.com

$110.04

-15.66 (-12.46%)

11:38
02/20/19
02/20
11:38
02/20/19
11:38
Recommendations
Wix.com analyst commentary  »

Wix.com strategy change…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 20

    Feb

  • 25

    Feb

  • 25

    Feb

  • 12

    Mar

  • 18

    Mar

11:35
02/20/19
02/20
11:35
02/20/19
11:35
General news
2-Yr FRN Note Auction Bid/Cover data reported »

2-Yr FRN Note Auction…

11:35
02/20/19
02/20
11:35
02/20/19
11:35
General news
2-Yr FRN Note Auction Total Amount data reported »

2-Yr FRN Note Auction…

DATA

Tableau

$128.02

1.08 (0.85%)

11:30
02/20/19
02/20
11:30
02/20/19
11:30
Options
Size time spread in Tableau Software paints a bullish picture »

Size time spread in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 06

    Mar

  • 07

    Mar

MO

Altria Group

$50.35

1.41 (2.88%)

11:26
02/20/19
02/20
11:26
02/20/19
11:26
Hot Stocks
Altria Group backs long-term adjusted EPS growth at 7%-9% annual rate »

In comments being…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.